We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Drug Transparency Laws Fall Short, USC Study Finds
Drug Transparency Laws Fall Short, USC Study Finds
Most enacted drug transparency laws are flawed because they don’t require the release of transaction prices at each stage of the pharmaceutical distribution process, according to researchers at the University of Southern California.